Mangoceuticals, Inc. (MGRX) stock
MGRXNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$0.16−0.00 (-0.19%)
Close on Nov 17, 2026Market cap $3.45MP/E –Yield –
Mangoceuticals r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for Mangoceuticals
Mangoceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?